CompletedNot Applicable

Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.

China220 participantsStarted 2025-03-12

Plain-language summary

This study aims to determine the optimal timing of endoscopic intervention after extracorporeal shock wave lithotripsy(ESWL) of chronic pancreatitis with pancreatic stones.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. symptomatic adult patients diagnosed with chronic pancreatitis and main pancreatic duct positive stones（\>5mm in diameter）
✓. no ERCP and ESWL history before the admission
✓. provides informed consent

Exclusion criteria

✕. suspected to have malignant tumors;
✕. history of pancreatic surgery or gastrojejunostomy (Billroth II);
✕. with end-stage disease;
✕. with contraindications to ESWL or ERCP, such as pregnancy, abdominal aortic aneurysm, etc.
✕. acute pancreatitis within 3 days
✕. pancreatic ascites

What they're measuring

Successful MPD Cannulation Rates

Timeframe: during ERCP procedure

Trial details

NCT IDNCT05270434

SponsorChanghai Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-18

View on ClinicalTrials.gov More Pancreatitis, Chronic trials